1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Argentina Pharmaceuticals and Healthcare Report Q4 2016

Argentina Pharmaceuticals and Healthcare Report Q4 2016

  • August 2016
  • -
  • Business Monitor International
  • -
  • 106 pages

Includes 3 FREE quarterly updates


BMI View:

The Argentinean pharmaceutical market will continue to experience downward pressure owing to a contraction in consumption indices in the near term. In the long term, however, market growth fundamentals will remain robust, creating commercial and investment opportunities for drugmakers. While the expected introduction of a national HTA agency over the coming quarters could create a new market access hurdle, the importance of value-adding innovative therapies will continue to be recognised by health sector stakeholders owing to the robust scientific and medical culture in the country. Headline Expenditure Projections Pharmaceuticals: ARS64.02bn (USD6.91bn) in 2015 to ARS79.31bn (USD5.57bn) in 2016; +23.9% in local currency terms and -19.5% in US dollar terms. Forecast unchanged in local currency terms and revised slightly upwards in US dollar terms from last quarter. Healthcare: ARS250.68bn (USD27.06bn) in 2015 to ARS319.01bn (USD22.39bn) in 2016; +27.3% in local currency terms and -17.3% in US dollar terms. Forecast revised upwards from last quarter.

Table Of Contents

Argentina Pharmaceuticals and Healthcare Report Q4 2016
BMI Industry View 7
Table: Headline Pharmaceutical and Healthcare Forecasts (2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Argentina 2012-2020) 14
Healthcare Market Forecast 15
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Argentina 2012-2020) 17
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Argentina 2012-2020) 18
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Argentina 2012-2020) 18
Prescription Drug Market Forecast 19
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Argentina 2012-2020) 21
Patented Drug Market Forecast 22
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Argentina 2012-2020) 24
Generic Drug Market Forecast 25
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Argentina 2012-2020) 27
OTC Medicine Market Forecast 28
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Argentina 2012-2020) 30
Pharmaceutical Trade Forecast 31
Table: Pharmaceutical Trade Data And Forecasts (Argentina 2014-2020) 33
Table: Pharmaceutical Trade Data And Forecasts local currency (Argentina 2014-2020) 34
Industry Risk Reward Index 35
Americas Risk/Reward Index 35
Argentina Risk/Reward Index 42
Rewards 42
Risks 43
Regulatory Review 44
Table: Product Registration, Annex I and II Listed Countries 45
Intellectual Property Issues 52
Pricing Regime 58
Table: Pharmaceutical Price Build-Up 59
Reimbursement Regime 59
Market Overview 60
Healthcare Sector 61
Table: Healthcare Resources (Argentina 2010-2015) 64
Table: Healthcare Personnel (Argentina 2010-2015) 64
Table: Healthcare Activity (Argentina 2010-2015) 65
Research and Development 65
Clinical Trials 69
Epidemiology 70
Competitive Landscape 72
Research-Based Industry 73
Table: Multinational Market Activity 76
Generic Drugmakers 77
Pharmaceutical Distribution 79
Pharmaceutical Retail Sector 80
Company Profile 83
GlaxoSmithKline 83
Laboratorios Bago 86
Novartis 89
Sanofi 92
Demographic Forecast 95
Demographic Outlook 95
Table: Population Headline Indicators (Argentina 1990-2025) 96
Table: Key Population Ratios (Argentina 1990-2025) 96
Table: Urban/Rural Population and Life Expectancy (Argentina 1990-2025) 97
Table: Population By Age Group (Argentina 1990-2025) 97
Table: Population By Age Group % (Argentina 1990-2025) 98
Glossary 100
Methodology 102
Pharmaceutical Expenditure Forecast Model 102
Healthcare Expenditure Forecast Model 102
Notes On Methodology 103
Risk/Reward Index Methodology 104
Index Overview 105
Table: Pharmaceutical Risk/Reward Index Indicators 105
Indicator Weightings 106

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.